@prefix cas: <http://identifiers.org/cas/> .
@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-Athens_Univ-AU105308 a mbo:MassSpectrum ;
    dcterms:creator "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens" ;
    dcterms:date "2016-02-25"^^xsd:date ;
    dcterms:identifier "MSBNK-Athens_Univ-AU105308" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Copyright (C) 2016 Department of Chemistry, University of Athens under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Bruker maXis Impact" ;
            mbo:collision_energy "20 eV" ;
            mbo:column_name "ACQUITY UPLC BEH Amide 1.7 um 2.1x100mm, Waters" ;
            mbo:flow_gradient "0/100 at 0-2 min, 95/5 at 12 min, 95/5 at 17 min, 0/100 at 17.1, 0/100 at 25 min" ;
            mbo:flow_rate "200 uL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "35000" ;
            mbo:retention_time "6.255 min" ;
            mbo:solvent "A Water with 0.01% formic acid and 1mM ammonium formate",
                "B Acetonitrile:Water 95:5 with 0.01% formic acid and 1mM ammonium formate" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",
                "Clarithromycin" ;
            mbo:ch_compound_class "N/A; Environmental Standard" ;
            mbo:ch_exact_mass 7.474769e+02 ;
            rdfs:seeAlso cas:81103-11-9,
                chemspider:10342604,
                pubchem:CID84029 ;
            schema:inChI "InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1" ;
            schema:inChIKey inchikey:AGOYDEPGAOXOCK-KCBOHYOISA-N ;
            schema:molecularFormula "C38H69NO13" ;
            schema:name "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",
                "Clarithromycin" ;
            schema:smiles "CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC" ] ;
    mbo:has_peak [ mbo:intensity 1.5556e+04 ;
            mbo:mz 1.161068e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 9 ],
        [ mbo:intensity 2.53512e+05 ;
            mbo:mz 5.913949e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 145 ],
        [ mbo:intensity 4.8712e+04 ;
            mbo:mz 5.923959e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 28 ],
        [ mbo:intensity 1.3048e+04 ;
            mbo:mz 7.164611e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 7 ],
        [ mbo:intensity 1.748424e+06 ;
            mbo:mz 7.48487e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 5.10496e+05 ;
            mbo:mz 7.494895e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 292 ],
        [ mbo:intensity 1.28852e+05 ;
            mbo:mz 7.504916e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 74 ],
        [ mbo:intensity 1.386e+04 ;
            mbo:mz 1.270746e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 8 ],
        [ mbo:intensity 6.21696e+05 ;
            mbo:mz 1.581172e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 355 ],
        [ mbo:intensity 5.1484e+04 ;
            mbo:mz 1.591204e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 29 ],
        [ mbo:intensity 5.5544e+04 ;
            mbo:mz 3.162115e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 32 ],
        [ mbo:intensity 9.956e+03 ;
            mbo:mz 3.172156e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 1.03344e+05 ;
            mbo:mz 5.583646e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 59 ],
        [ mbo:intensity 3.158e+04 ;
            mbo:mz 5.593678e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 18 ],
        [ mbo:intensity 7.87576e+05 ;
            mbo:mz 5.90391e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 450 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 3.242081e+02 ;
            mbo:precursor_mz 7.484842e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 15 ;
    mbo:pk_splash "splash10-0002-0200040900-019a2ff71b684e7b0977" ;
    rdfs:comment "INTERNAL_ID 1053" ;
    skos:definition "Clarithromycin; LC-ESI-QTOF; MS2; HILIC; CE: 20 eV; R=35000; [M+H]+" .

